Minoo Battiwalla, MD - TriStar Bone Marrow Transplant

Dr. Stephen Strickland is a hematologist at Tristar Bone Marrow Transplant in Nashville, TN. He is board-certified in both hematology and medical oncology and he is affiliated with Tristar Centennial Medical Center and Sarah Cannon Cancer Institute. Dr. Strickland has extensive clinical expertise in treating blood cancers including leukemia, lymphoma and conditions like MDS.

Dr. Andrew S Kennedy joined Physician Services Group in 2012 at Sarah Cannon Cancer Center. Dr. Kennedy is a radiation oncologist with expertise in GI, GYN, Breast, Lung, and other cancers including blood (lymphomas) and pediatric cancers. In addition to being skilled in stereotactic radiotherapy (SRS and SBRT), he is accomplished in brachytherapy in all body areas (placing radioactive sources in or beside tumors in the body). He continues to follow many patients he has treated over the past 20 years of practice and is actively working in many national cancer quality improvement committees. Dr. Kennedy has given numerous presentations on radiation therapy for the treatment of colorectal and liver cancer and was instrumental in reintroducing an important new treatment for liver cancer called infusion of microspheres. This revolutionary treatment offers hope to patients who have not had success with chemotherapy. He has written dozens of articles, book chapters and abstracts on radiation oncology and has been invited to give presentations on radiation therapy for GI cancers and infusion of microspheres at the premier medical conferences in the United States and Europe. Dr. Kennedy is a graduate of the Loma Linda School of Medicine in California and completed his residency at The University of North Carolina at Chapel Hill. Nationally, he served as a member of the Board of Chancellors for the American College of Radiation Oncology and is a Fellow of the College.

Dr. Jeremy Pantin received his medical degree from the University of the West Indies, Trinidad and Tobago. He completed his internal medicine residency at Howard University Hospital in Washington, DC, and fellowships in Hematology, Medical Oncology, and Blood and Marrow Transplantation at the National Heart Lung and Blood Institute (NHLBI) at the National Institutes of Health in Bethesda, MD. At completion of his training, Dr. Pantin continued as Staff Clinician at the NHLBI before moving to Augusta University at the Medical College of Georgia (MCG) in Augusta, GA. At MCG, Dr. Pantin introduced haploidentical and cord blood allogeneic transplantation, and started the program for allogeneic transplantation for sickle cell disease. Dr. Pantin also served as the Interim Medical Director of the Blood and Marrow Transplant Program at MCG and successfully led the program to continued FACT reaccreditation. Additionally, Dr. Pantin was the Hematology and Medical Oncology Fellowship Program director and served on the Georgia Cancer Center?s Institutional Review Board. Dr. Pantin is board certified in Internal Medicine, Hematology, and Medical Oncology. He is a Fellow of the American College of Physicians and a member of the American Society of Hematology and the American Society for Blood and Marrow Transplantation.